ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,388,000 | -9.7% | 20,000 | 0.0% | 0.03% | -16.2% |
| Q4 2020 | $1,537,000 | -31.5% | 20,000 | -33.3% | 0.04% | -57.0% |
| Q3 2020 | $2,244,000 | -52.5% | 30,000 | -60.0% | 0.09% | -52.2% |
| Q2 2020 | $4,721,000 | +12.4% | 75,000 | -25.0% | 0.18% | -7.7% |
| Q1 2020 | $4,200,000 | -46.3% | 100,000 | -42.0% | 0.20% | -37.5% |
| Q4 2019 | $7,826,000 | -0.8% | 172,300 | 0.0% | 0.31% | -35.0% |
| Q3 2019 | $7,886,000 | -32.7% | 172,300 | -13.8% | 0.48% | -28.8% |
| Q2 2019 | $11,726,000 | +4.6% | 200,000 | -20.0% | 0.67% | -11.0% |
| Q1 2019 | $11,207,000 | -4.1% | 250,000 | -16.7% | 0.76% | -20.2% |
| Q4 2018 | $11,685,000 | -38.1% | 300,000 | -26.8% | 0.95% | -22.6% |
| Q3 2018 | $18,868,000 | -3.8% | 410,000 | -8.9% | 1.23% | -15.6% |
| Q2 2018 | $19,620,000 | +297.3% | 450,000 | +260.0% | 1.45% | +294.6% |
| Q1 2018 | $4,938,000 | – | 125,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |